Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Controlled Clinical Trial
. 2007 Sep;78(9):1012-3.
doi: 10.1136/jnnp.2006.102731.

Treatment of Guillain-Barré syndrome with mycophenolate mofetil: a pilot study

M P J Garssen  1 , R van Koningsveld, P A van Doorn, I S J Merkies, M Scheltens-de Boer, J A van Leusden, I N van Schaik, W H J P Linssen, F Visscher, A M Boon, C G Faber, J Meulstee, M J J Prick, L H van den Berg, H Franssen, J A P Hiel, P Y K van den Bergh, C J M Sindic
Affiliations
Controlled Clinical Trial

Treatment of Guillain-Barré syndrome with mycophenolate mofetil: a pilot study

M P J Garssen et al. J Neurol Neurosurg Psychiatry. 2007 Sep.

Erratum in

  • J Neurol Neurosurg Psychiatry. 2007 Dec;78(12):1416. Merkies, ISJ [added]; Scheltens-de Boer M [added]; van Leusden, JA [added]; van Schaik, IN [added]; Linssen, WHJP [added]; Visscher, F [added]; Boon, AM [added]; Faber, CG [added]; Meulstee, J [added]; Prick, MJJ [added]; van den Berg, LH [added]; Franssen
No abstract available

PubMed Disclaimer

Conflict of interest statement

Competing interests: None.

References

    1. Hughes R A, Raphael J C, Swan A V.et al Intravenous immunoglobulin for Guillain–Barré syndrome. Cochrane Database Syst Rev 20041CD002063 - PubMed
    1. Van Koningsveld R, Schmitz P I, Meché F G.et al Effect of methylprednisolone when added to standard treatment with intravenous immunoglobulin for Guillain–Barré syndrome: randomised trial. Lancet 2004363192–196. - PubMed
    1. Willison H J. The immunobiology of Guillain–Barré syndromes. J Peripher Nerv Syst 20051094–112. - PubMed
    1. Vermersch P, Stojkovic T, de Seze J. Mycophenolate mofetil and neurological diseases. Lupus 200514(Suppl 1)S42–S45. - PubMed
    1. Cauchy V, Cornblath D R, Griffin J W.et al Mycophenolate mofetil: a safe and promising immunosuppressant in neuromuscular diseases. Neurology 20015694–96. - PubMed

Publication types

MeSH terms